IVAX LABORATORIES,INC. – Trademark Portfolio

Entity Type: 03

IVAX LABORATORIES,INC. holds 28 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 27 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PROAIR. The owner is based in MIAMI, FL.

4400 BISCAYNE BOULEVARD

MIAMI, FL 33137

28 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Page 1 of 2 (28 results)

Trademark Classifications

IVAX LABORATORIES,INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (27 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (10 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does IVAX LABORATORIES,INC. have?

IVAX LABORATORIES,INC. has 28 U.S. trademarks filed with the USPTO. Of these, 1 registered, 20 abandoned, 7 cancelled.

What trademark classes does IVAX LABORATORIES,INC. file in?

IVAX LABORATORIES,INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are IVAX LABORATORIES,INC.'s most well-known trademarks?

IVAX LABORATORIES,INC.'s registered trademark portfolio includes well-known marks such as PROAIR. These are among 1 currently registered trademark in the portfolio.

What is IVAX LABORATORIES,INC.'s trademark registration success rate?

IVAX LABORATORIES,INC. has a 4% trademark registration rate, with 1 out of 28 resolved applications resulting in successful registration. Currently, 0 applications are pending review.